FAQ
In June 2021, the FDA has approved drugs that have semaglutide as an active ingredient – Wegovy, Ozempic, and Rybelsus. Like most medications, semaglutide has side effects. The most common mild side effects are nausea, diarrhea, vomiting, indigestion, and constipation. Semaglutide also may cause serious side effects, including inflammation of the pancreas (pancreatitis), changes in vision, low blood sugar (hypoglycemia), kidney problems (kidney failure), and serious allergic reactions.
Patients with the following conditions should not take semaglutide:
- diabetic retinopathy, a type of damage to the eye from diabetes
- low blood sugar
- disease of the gallbladder
- decreased kidney function
- pancreatitis
- medullary thyroid cancer
- multiple endocrine neoplasia type 2
- family history of medullary thyroid carcinoma
- kidney disease with likely reduction in kidney function
- pregnant or plan to become pregnant, breastfeeding or plan to breastfeed
In a 69-week trial, patients lost an average of 15%
of their body weight taking semaglutide. However, participants, who introduced “healthy” changes to their lifestyle, 33% of those person lost up to 20% and more of their initial body weight. We can help you do the same.
Semaglutide is a once-weekly injection.
Semaglutide must be kept refrigerated at all times when not in use.
You can find our Payment, Delivery and Refunds policy at these links Payment,
Delivery and Refund Policy
Nevada
